The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 13, 2015
Filed:
Apr. 04, 2012
Applicants:
Wen-lian Wu, Edison, NJ (US);
Duane A. Burnett, Bernardsville, NJ (US);
William J. Greenlee, Teaneck, NJ (US);
Inventors:
Wen-Lian Wu, Edison, NJ (US);
Duane A. Burnett, Bernardsville, NJ (US);
William J. Greenlee, Teaneck, NJ (US);
Assignee:
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/352 (2006.01); C07D 493/06 (2006.01); A61K 31/5377 (2006.01); A61K 45/06 (2006.01); A61K 31/453 (2006.01); C07D 493/04 (2006.01); A61K 31/35 (2006.01); A61K 31/4178 (2006.01); A61K 31/496 (2006.01); A61K 31/397 (2006.01); A61K 31/665 (2006.01); A61K 31/4025 (2006.01); A61K 31/422 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5377 (2013.01); A61K 45/06 (2013.01); A61K 31/453 (2013.01); C07D 493/04 (2013.01); A61K 31/35 (2013.01); A61K 31/4178 (2013.01); A61K 31/496 (2013.01); A61K 31/397 (2013.01); A61K 31/665 (2013.01); A61K 31/4025 (2013.01); A61K 31/422 (2013.01);
Abstract
Disclosed herein are compounds of Formula (I) and pharmaceutically acceptable salts thereof, wherein each of the substituents is given the definition as set forth in the specification and claims. Also disclosed are pharmaceutical compositions containing the compound of Formula (I) and use of the compound in the treatment of neurodegenerative diseases or conditions such as Alzheimer's disease.